iifl-logo-icon 1
iifl-logo-icon 1Budget 2024
iifl-logo-icon 1
Home

Procter & Gamble Health Ltd Share Price

₹5,277.6
(3.00%)
Jul 23, 2024|03:32:34 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹5,123.95
  • Day's High₹5,318.9
  • 52 Wk High₹5,642.85
  • Prev. Close₹5,123.95
  • Day's Low₹5,123.95
  • 52 Wk Low ₹4,636.55
  • Turnover (lac)951.07
  • P/E39.77
  • Face Value₹10
  • Book Value₹563.31
  • EPS128.93
  • Mkt. Cap (Cr.)₹8,760.82
  • Div. Yield1.2
No Records Found

Procter & Gamble Health Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹5,123.95

Prev. Close

₹5,123.95

Turnover(Lac.)

₹951.07

Day's High

₹5,318.9

Day's Low

₹5,123.95

52 Week's High

₹5,642.85

52 Week's Low

₹4,636.55

Book Value

₹563.31

Face Value

₹10

Mkt Cap (₹ Cr.)

8,760.82

P/E

39.77

EPS

128.93

Divi. Yield

1.2

Procter & Gamble Health Ltd Corporate Action

24 Aug 2023

12:00 AM

BookCloser

arrow

6 Feb 2024

12:00 AM

Dividend

Dividend Amount: 50

Record Date: 14 Feb, 2024

arrow

24 Aug 2023

12:00 AM

AGM

Announcement Date: 24 Aug, 2023

arrow

27 Mar 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Procter & Gamble Health Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Procter & Gamble Health Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:28 PM
Jun-2024Mar-2024Dec-2023Sep-2023
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 51.81%

Foreign: 51.81%

Indian: 0.00%

Non-Promoter- 20.95%

Institutions: 20.95%

Non-Institutions: 27.23%

Custodian: 0.00%

Read More
Share Price

Procter & Gamble Health Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Jun-2023Jun-2022Jun-2021Jun-2020

Equity Capital

16.6

16.6

16.6

16.6

Preference Capital

0

0

0

0

Reserves

734.29

599.89

687.11

889.74

Net Worth

750.89

616.49

703.71

906.34

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Jun-2021Jun-2020Dec-2017Dec-2016

Revenue

1,008.73

1,355.86

1,103.96

992.56

yoy growth (%)

-25.6

22.81

11.22

5.64

Raw materials

-314.82

-431.44

-441.09

-411.54

As % of sales

31.2

31.82

39.95

41.46

Employee costs

-150.47

-182.93

-169.64

-154.23

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Jun-2021Jun-2020Dec-2017Dec-2016

Profit before tax

233.28

354.85

135.19

115.17

Depreciation

-30.04

-29.45

-26.4

-24.81

Tax paid

-56.48

-100.77

-58.28

-36.04

Working capital

-233.3

269.12

35.2

57.07

Other operating items

View Cash Flow
Loading...
Y/e 31 MarJun-2021Jun-2020Dec-2017Dec-2016

Growth matrix (%)

Revenue growth

-25.6

22.81

11.22

5.64

Op profit growth

-21.99

129.18

19.07

38.5

EBIT growth

-34.03

162.48

17.38

38.2

Net profit growth

-30.41

170.55

18.67

47.74

View Ratios

No Record found

View Annually Results

Procter & Gamble Health Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Procter & Gamble Health Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

S N Talwar

Independent Director

Rani A Jadhav

Managing Director

Milind Thatte

Director (Finance) & CFO

Amit Gupta

Director

Aalok Agrawal

Company Sec. & Compli. Officer

Zeal Shah

Director

Elizabeth Desmond

Independent Director

S Madhavan

Executive Director

Lokesh Chandak

Non Executive Director

Seema Sambasivan

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by Procter & Gamble Health Ltd

Summary

Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products. They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs.The company operates in two business divisions, namely Pharmaceuticals and Chemicals. The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products. The Chemicals business comprises of Bulk Drugs and Pigments. Segment revenue relating to the Chemicals business consists of bulk drugs, pigments and active pharmaceutical ingredients.Merck Ltd was incorporated in the year 1967 as E Merck (India) Ltd. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities. The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations.The company started their operations as a manufacturer of ph
Read More

Company FAQs

What is the Procter & Gamble Health Ltd share price today?

Down Arrow

The Procter & Gamble Health Ltd shares price on N/A is Rs.₹5290 today.

What is the Market Cap of Procter & Gamble Health Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Procter & Gamble Health Ltd is ₹8781.40 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Procter & Gamble Health Ltd?

Down Arrow

The PE and PB ratios of Procter & Gamble Health Ltd is 39.77 and 10.56 as of 23 Jul ‘24

What is the 52 Week High and Low of Procter & Gamble Health Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Procter & Gamble Health Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Procter & Gamble Health Ltd is ₹4640.3 and ₹5640 as of 23 Jul ‘24

What is the CAGR of Procter & Gamble Health Ltd?

Down Arrow

Procter & Gamble Health Ltd's CAGR for 5 Years at 2.95%, 3 Years at -2.32%, 1 Year at -0.45%, 6 Month at -2.13%, 3 Month at 9.09% and 1 Month at 2.22%.

What is the shareholding pattern of Procter & Gamble Health Ltd?

Down Arrow

The shareholding pattern of Procter & Gamble Health Ltd is as follows:
Promoters - 51.82 %
Institutions - 20.95 %
Public - 27.23 %

QUICKLINKS FOR Procter & Gamble Health Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.